The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-utility of apixaban and rivaroxaban in the thromboprophylaxis of cancer patients treated with chemotherapy in Spain.
 
Laura Ortega
Consulting or Advisory Role - Sanofi
Speakers' Bureau - LEO Pharma; Sanofi
Travel, Accommodations, Expenses - Amgen; Pierre Fabre
 
Andrés J. Muñoz Martín
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Pfizer; Celgene; Daiichi Sankyo; Incyte; LEO Pharma; Lilly; MSD Oncology; Roche; Sanofi
Speakers' Bureau - Bayer; Menarini; Rovi; SERVIER; STADA
Research Funding - Celgene; LEO Pharma; Sanofi
Patents, Royalties, Other Intellectual Property - Risk assessment model in venous thromboembolism in cancer patients
Travel, Accommodations, Expenses - Amgen; Celgene; Merck Serono; Roche
 
Carlos Rubio-Terres
Consulting or Advisory Role - Pfizer
 
Dario Rubio-Rodriguez
Consulting or Advisory Role - Pfizer
 
Jose Manuel Soria
No Relationships to Disclose